NYSE · Healthcare · Holders
Abbott Laboratories (ABT) Institutional Ownership & Insider Trading History
Top ABT institutional shareholders, filing changes, and Form 4 insider activity with filters for buys, sales, option exercises, gifts, and tax withholding.
- Last confirmed price
- $103.70+1.16%
- Oct 23, 2026, 4:01 PM EDT · Prices may be delayed
Data dates
Prices as of Oct 23, 4:01 PM EDT · Fundamentals checked Oct 25, 3:55 AM EDT · Statement period ended Mar 31, 2026
Ownership read
ABT insider transaction activity: Mixed, sale-heavy.
Blackrock Inc. is the largest institutional holder. 22 classified sales and 5 classified purchases appear in the recent insider records. Use the filters below to separate open-market activity from option exercises, gifts, awards, and tax withholding.
Insider flow
ABT
Directional bars ignore awards, gifts, conversions, and tax withholding rows.
Top holder
152.56M
Blackrock Inc.
Insider transaction activity
Mixed, sale-heavy
$126.57M sold / $4.4M bought
Observations shown
87
10 holder / 77 insider
- Increased / initiated
- Unavailable
- Prior positions were not supplied
- Insider rows
- 77
- Transaction dates shown per row
Ownership concentration and transaction activity
- Top 10 reported holders
- 35.64% outstanding
- Changes with share-count history
- Prior-position data unavailable
- New / exited positions
- Prior-position data unavailable
- Largest increase with share-count history
- Prior share counts unavailable
These changes cover the holders shown. A holder missing from this list may still own shares. Compare positions from the same reporting quarters.
Net shares sold: 972,577
Sale-code S shares minus purchase-code P shares in this sample. Includes disclosed plans and unknown plan status; excludes grants, gifts, exercises and withholding. This is activity, not sentiment.
- Purchase / sale; plan unknown: 27
- Conversion / exercise: 5
- Grant: 44
- Gift: 1
Top 10 institutional holders
Abbott Laboratories (ABT) institutional ownership
Ranked by reported share count, with position changes and separate position and filing dates where ownership data supplies them.
| # | Institution | % held | Shares | Position / filing date |
|---|---|---|---|---|
| 1 | 8.82% | 152.56M | Position as of Jun 30, 2026Filing date unknown | |
| 2 | 6.57% | 113.75M | Position as of Jun 30, 2026Filing date unknown | |
| 3 | 4.68% | 80.93M | Position as of Jun 30, 2026Filing date unknown | |
| 4 | 3.45% | 59.67M | Position as of Jun 30, 2026Filing date unknown | |
| 5 | 2.83% | 49.02M | Position as of Jun 30, 2026Filing date unknown | |
| 6 | 2.27% | 39.22M | Position as of Jun 30, 2026Filing date unknown | |
| 7 | 2.13% | 36.91M | Position as of Jun 30, 2026Filing date unknown | |
| 8 | Capital International Investors | 2.00% | 34.65M | Position as of Jun 30, 2026Filing date unknown |
| 9 | 1.54% | 26.61M | Position as of Jun 30, 2026Filing date unknown | |
| 10 | 1.35% | 23.35M | Position as of Jun 30, 2026Filing date unknown |
Recent insider transactions
Abbott Laboratories (ABT) Form 4 filings
Action codes are translated so open-market buys and sales are separate from awards, gifts, conversions, and tax withholding. Window: Jan 28, 2025–Sep 2, 2026 · 77 records.
| # | Insider | % company | Action | Shares | Price | Value | Transaction / filing |
|---|---|---|---|---|---|---|---|
| 1 | MCCOY JOHN A. JR Officer | <0.01% | SaleOpen-market or direct sale reported on Form 4.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 27 | $109.56 | $2,958 | Sep 2, 2026Filing date unavailableOriginal filing link unavailable |
| 2 | FORD ROBERT B. Chief Executive Officer | 0.02% | SaleOpen-market or direct sale reported on Form 4.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 398.83K | $115.85 | $46,204,798 | Aug 25, 2026Filing date unavailableOriginal filing link unavailable |
| 3 | FORD ROBERT B. Chief Executive Officer | 0.02% | ConversionConversion or exercise of derivative securities. Read alongside sale rows before treating it as bearish.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 398.83K | $54.02 | $21,545,946 | Aug 25, 2026Filing date unavailableOriginal filing link unavailable |
| 4 | MORRONE LOUIS H Officer | <0.01% | SaleOpen-market or direct sale reported on Form 4.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 5.85K | $109.83 | $642,506 | Aug 11, 2026Filing date unavailableOriginal filing link unavailable |
| 5 | STRATTON JOHN G. Director | <0.01% | PurchaseOpen-market or direct purchase reported on Form 4.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.00K | $86.82 | $173,640 | May 7, 2026Filing date unavailableOriginal filing link unavailable |
| 6 | STARKS DANIEL J Director | <0.01% | PurchaseOpen-market or direct purchase reported on Form 4.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 10.00K | $92.65 | $926,537 | Apr 27, 2026Filing date unavailableOriginal filing link unavailable |
| 7 | AHUJA NITA M.D. Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.29K | No cash value | No cash value | Apr 24, 2026Filing date unavailableOriginal filing link unavailable |
| 8 | BABINEAUX CLAIRE FONTENOT Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.29K | No cash value | No cash value | Apr 24, 2026Filing date unavailableOriginal filing link unavailable |
| 9 | MCDEW DARREN W Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.29K | No cash value | No cash value | Apr 24, 2026Filing date unavailableOriginal filing link unavailable |
| 10 | GONZALEZ PATRICIA PAOLA Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.29K | No cash value | No cash value | Apr 24, 2026Filing date unavailableOriginal filing link unavailable |
| 11 | MCKINSTRY NANCY Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.29K | No cash value | No cash value | Apr 24, 2026Filing date unavailableOriginal filing link unavailable |
| 12 | CONROY KEVIN T Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 2.29K | No cash value | No cash value | Apr 24, 2026Filing date unavailableOriginal filing link unavailable |
Frequently asked
Questions about this quote
Who are the largest ABT shareholders?
Blackrock Inc. is the largest reported institutional holder of ABT, with 152.56 million shares, or about 8.82% of shares outstanding.
What does the institutional filing activity show for ABT?
Abbott Laboratories has 10 institutional rows on file. Previous position sizes are unavailable, so increases and reductions cannot be determined.
What insider transactions are available for ABT?
TECHi shows 77 dated ABT insider transactions through Sep 2, 2026, with transaction types kept separate so administrative actions are not presented as open-market trades.
Are ABT insiders buying or selling?
The displayed ABT activity reads Mixed, sale-heavy: 22 sales and 5 purchases. Other transaction types remain separate.
Who is the most active reported ABT insider?
FORD ROBERT B. has the largest absolute share movement in the displayed ABT filing rows, totaling 1.54 million shares. The action labels provide the transaction context.
What this page answers
Check who owns the float and whether insiders are active.
Explore Institutional concentration, insider transaction pattern, and float context.
Keep in mind Filings are delayed or transactions are administrative rather than economic.
Market closed
Regular hours: 9:30 AM–4:00 PM America/New_York
Next open: 2026-10-26 · 9:30 AM America/New_York
Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.
Shortcuts
With research tools focused: / search · W watchlist · C compare · F financials · E earnings · N news · T technicals · Esc close